TOBRA-DAY tobramycin (as sulfate) 500mg/5 mL Injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

tobra-day tobramycin (as sulfate) 500mg/5 ml injection vial

phebra pty ltd - tobramycin sulfate, quantity: 762.24 mg (equivalent: tobramycin, qty 500 mg) - injection, concentrated - excipient ingredients: sulfuric acid; water for injections; sodium hydroxide - tobra-day is indicated for once daily intravenous use in the treatment of cystic fibrosis patients (greater than 5 years old) with acute pulmonary exacerbations caused by susceptible organisms.

BREVIBLOC esmolol hydrochloride 2.5g/10mL injection Australia - English - Department of Health (Therapeutic Goods Administration)

brevibloc esmolol hydrochloride 2.5g/10ml injection

phebra pty ltd - esmolol hydrochloride, quantity: 250 mg/ml - injection, concentrated - excipient ingredients: propylene glycol; ethanol; water for injections; hydrochloric acid; sodium hydroxide; sodium acetate; glacial acetic acid - supraventricular tachycardia - for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. esmolol is also indicated in non-compensatory sinus tachycardia where, in the physician's judgement, the rapid heart rate requires specific intervention. esmolol is not intended for use in chronic settings where transfer to another agent is anticipated, or for treatment periods greater than 24 hours duration.

CALDOLOR ibuprofen 800mg/8mL concentrated solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

caldolor ibuprofen 800mg/8ml concentrated solution for injection vial

phebra pty ltd - ibuprofen, quantity: 100 mg/ml - injection, concentrated - excipient ingredients: hydrochloric acid; water for injections; arginine - caldolor injection is indicated in adults for the management of acute mild to moderate post-operative pain and moderate to severe post-operative pain with adjunctive reduced morphine dosage, where an intravenous route of administration is considered clinically necessary.,caldolor is indicated for the reduction of fever in adults where an intravenous route of administration is considered clinically necessary.

CALDOLOR Australia - English - Department of Health (Therapeutic Goods Administration)

caldolor

phebra pty ltd - ibuprofen, quantity: 100 mg/ml - injection, concentrated - excipient ingredients: arginine; water for injections; hydrochloric acid - caldolor injection is indicated in adults for the management of acute mild to moderate post-operative pain and moderate to severe post-operative pain with adjunctive reduced morphine dosage, where an intravenous route of administration is considered clinically necessary.,caldolor is indicated for the reduction of fever in adults where an intravenous route of administration is considered clinically necessary.

BENZATROPINE PHEBRA SOLUTION FOR INJECTION 2 MG2 ML Singapore - English - HSA (Health Sciences Authority)

benzatropine phebra solution for injection 2 mg2 ml

phebra (se asia) pte. ltd. - benzatropine mesilate - injection, solution - benzatropine mesilate 2.0 mg/2ml

Anusol Ointment Australia - English - Department of Health (Therapeutic Goods Administration)

anusol ointment

church and dwight australia pty ltd - zinc oxide, quantity: 107.5 mg/g; benzyl benzoate, quantity: 12.5 mg/g; peru balsam, quantity: 18.8 mg/g - ointment - excipient ingredients: magnesium stearate; white soft paraffin; kaolin; castor oil; theobroma oil; wool fat - for the relief of itching, burning and soreness of haemorrhoids and minor rectal inflammations and irritation. useful also in minor skin irritation, itching and chafing.

BUPIVACAINE 0.25% WITH ADRENALINE 1:400,000 PHEBRA bupivacaine HCl 50 mg/20 mL with  adrenaline 50 microgram/20 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

bupivacaine 0.25% with adrenaline 1:400,000 phebra bupivacaine hcl 50 mg/20 ml with adrenaline 50 microgram/20 ml solution for injection vial

phebra pty ltd - bupivacaine hydrochloride monohydrate, quantity: 52.8 mg (equivalent: bupivacaine hydrochloride, qty 50 mg); adrenaline (epinephrine) acid tartrate, quantity: 90 microgram (equivalent: adrenaline (epinephrine), qty 50 microgram) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium metabisulfite; water for injections - bupivacaine with adrenaline phebra solution is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows:,surgical anaesthesia - epidural block for surgery. - field block (minor and major nerve blocks and infiltration).,analgesia - intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. - field block (minor nerve block and infiltration).